Concepedia

Peter F. Thall

PF

222

Publications

22.3K

Citations

79

H-Index

1974

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Peter F. Thall is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and health sciences.

ORCID

Top concepts

Publications per year

1974–2024

222

Publications

222

Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors

Enli Liu, David Marín, Pinaki P. Banerjee et al. · New England Journal of Medicine · 2020 · 2K citations · Full text

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

Robert G. Maki, J. Kyle Wathen, Shreyaskumar Patel et al. · Journal of Clinical Oncology · 2007 · 719 citations

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri et al. · Blood · 2001 · 570 citations

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Sergio Giralt, Peter F. Thall, Issa F. Khouri et al. · Blood · 2001 · 516 citations

Dose‐Finding Based on Efficacy–Toxicity Trade‐Offs

Peter F. Thall, John D. Cook · Biometrics · 2004 · 497 citations

, , +14

Rows per page

1–5 of 222